Background illustration for clinical trials search

Paid Clinical Trials Glenview

Discover 2,376 paid clinical trials in Glenview, Illinois. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer

for
Carcinoma, Non-Small Cell Lung
Location: Chicago IL, Decatur IL, Bridgeton MO, Owensboro KY,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06868277

Phase3, Recruiting

Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having HFpEF

for
Heart Failure With Preserved Ejection Fraction (HFpEF
Location: Chicago IL, Ann Arbor MI, St Louis MO, Rochester MN,
Sponsor: Axon Therapies, Inc.

Sex: All

Age: 40+

Code: NCT04592445

Recruiting

Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer

for
Gastric Cancer, Peritoneal Carcinomatosis
Location: Chicago IL
Sponsor: University of Chicago

Sex: All

Age: 18+

Code: NCT04107077

Phase2, Recruiting

Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor

for
Patients With Non-Small Cell Lung Cancer
Location: Chicago IL, Nashville TN, Smyrna TN, Franklin TN,
Sponsor: OSE Immunotherapeutics

Sex: All

Age: 18+

Code: NCT06472245

Phase3, Recruiting

Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source

for
Pancreatic Cancer
Location: Oak Lawn IL
Sponsor: CivaTech Oncology

Sex: All

Age: 18+

Code: NCT02843945

Phase1, Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

for
Advanced Non-small Cell Lung Cancer, HER2 Mutation
Location: Chicago IL, Maumee OH, Cincinnati OH, Pittsburgh PA,
Sponsor: Bayer

Sex: All

Age: 18+

Code: NCT06452277

Phase3, Recruiting

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

for
Carcinoma, Non-Small-Cell Lung
Location: Chicago IL, North Chicago IL, Milwaukee WI, Madison WI,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06890598

Phase3, Recruiting

Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System

for
Type 2 Diabetes Mellitus, Type 1 Diabetes Mellitus
Location: Chicago IL, Indianapolis IN, Detroit MI, Minneapolis MN,
Sponsor: Insulet Corporation

Sex: All

Age: 14 - 70+

Code: NCT07579702

Recruiting

Trial in HPV Prevention for the U.S. Vietnamese Community

for
HPV-related Cancers, HPV Vaccination
Location: Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 18+

Code: NCT07637630

Recruiting

Kidney Precision Medicine Project

for
Acute Kidney Failure, Acute Kidney Insufficiency,
Location: Chicago IL, Rochester MN, Cleveland OH, Minneapolis MN,
Sponsor: Icahn School of Medicine at Mount Sinai

Sex: All

Age: 18+

Code: NCT04334707

Recruiting

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia
Location: Chicago IL, Ottawa IL, Peru IL, Dixon IL, Princeton IL,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 65+

Code: NCT07321652

Phase3, Recruiting

A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer

for
Advanced Breast Cancer
Location: Chicago IL, Milwaukee WI, Madison WI, Grand Rapids MI,
Sponsor: Stemline Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06638307

Phase1, Recruiting

The REACH-OUT Trial

for
Hypertension, Reproductive Behavior, Primary Health Care,
Location: Chicago IL
Sponsor: Northwestern University

Sex: Female

Age: 18 - 44

Code: NCT07540143

Recruiting

A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

for
Metastatic Gastric Adenocarcinoma,
Location: Chicago IL, Hinsdale IL, Bridgeton MO, Nashville TN,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT07043400

Phase3, Recruiting

A Comparison of the dermaPACE® (Pulsed Acoustic Cellular Expression) Device in Conjunction With Standard of Care Versus Standard of Care Alone in the Treatment of Diabetic Foot Ulcers

for
Diabetic Foot Ulcers
Location: Chicago IL, Southfield MI, Hamilton, Kittaning PA,
Sponsor: SANUWAVE, Inc.

Sex: All

Age: 22+

Code: NCT01824407

Phase3, Recruiting

REVEAL: A Phase 3 Study of Obudanersen (ION582) in Angelman Syndrome

for
Angelman Syndrome
Location: Chicago IL, Cincinnati OH, Columbus OH, London,
Sponsor: Ionis Pharmaceuticals, Inc.

Sex: All

Age: 2 - 50

Code: NCT06914609

Phase3, Recruiting

A Study Evaluating the Safety and Efficacy of PRV111, PRV211, and PRV131 in Subjects With Oral and Lung Cancers

for
Oral Squamous Cell Carcinoma
Location: Chicago IL, Cleveland OH, Miami FL, Duarte CA
Sponsor: Privo Technologies

Sex: All

Age: 18 - 70+

Code: NCT05893888

Phase2, Phase3, Recruiting

Cemiplimab for the Treatment of Incurable Metastatic or Unresectable NUT Carcinoma

for
Metastatic NUT Carcinoma, Unresectable NUT Carcinoma
Location: Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 18+

Code: NCT07050186

Phase2, Recruiting

Epcoritamab and Lenalidomide in Treating Patients With Refractory or Relapsed Immunodeficiency-Related Large B-Cell Lymphoma

for
Recurrent B-Cell Non-Hodgkin Lymphoma,
Location: Chicago IL
Sponsor: Reem Karmali

Sex: All

Age: 18+

Code: NCT06723457

Phase2, Recruiting

Elacestrant vs Elacestrant Plus a CDK4/6 Inhibitor in Patients With ERpositive/HER2-negative Advanced or Metastatic Breast Cancer

for
Estrogen-receptor-positive Breast Cancer,
Location: Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 18+

Code: NCT06062498

Phase2, Recruiting